StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

CannaPharmaRx's shares outstanding was 1.27B at Sep 30, 2026. For fiscal 2025 it was 663M, up 6.0% from the year before. Over ten years it grew 45.7% a year on average. The highest annual figure on record is 663M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025663M+6.0%
FY2024Dec 31, 2024625M+102.4%
FY2023Dec 31, 2023309M+46.4%
FY2022Dec 31, 2022211M+182.6%
FY2021Dec 31, 202175M+83.5%
FY2020Dec 31, 202041M+30.6%
FY2019Dec 31, 201931M+73.5%
FY2018Dec 31, 201818M+0.0%
FY2017Dec 31, 201718M0.0%
FY2016Dec 31, 201618M+17.1%
FY2015Dec 31, 201515M+38.6%
FY2014Dec 31, 201411M+364.2%
FY2013Dec 31, 20132M0.0%
FY2012Dec 31, 20122M0.0%
FY2011Dec 31, 20112M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 20261.27B+91.7%
Q2 FY2026Jun 30, 2026682M+3.0%
Q1 FY2026Mar 31, 2026670M+1.1%
Q4 FY2025Dec 31, 2025663M-0.0%
Q3 FY2025Sep 30, 2025663M0.0%
Q2 FY2025Jun 30, 2025663M+0.7%
Q1 FY2025Mar 31, 2025663M+89.0%
Q4 FY2024Dec 31, 2024663M+85.3%
Q3 FY2024Sep 30, 2024663M+124.5%
Q2 FY2024Jun 30, 2024658M+119.6%
Q1 FY2024Mar 31, 2024351M+19.7%
Q4 FY2023Dec 31, 2023358M+41.4%
Q3 FY2023Sep 30, 2023295M+22.4%
Q2 FY2023Jun 30, 2023300M+50.0%
Q1 FY2023Mar 31, 2023293M+96.3%
Q4 FY2022Dec 31, 2022253M+132.2%
Q3 FY2022Sep 30, 2022241M+185.6%
Q2 FY2022Jun 30, 2022200M+249.1%
Q1 FY2022Mar 31, 2022149M+210.6%
Q4 FY2021Dec 31, 2021109M+210.9%
Q3 FY2021Sep 30, 202184M+112.5%
Q2 FY2021Jun 30, 202157M+43.1%
Q1 FY2021Mar 31, 202148M+31.7%
Q4 FY2020Dec 31, 202035M-3.6%
Q3 FY2020Sep 30, 202040M+17.1%
Q2 FY2020Jun 30, 202040M+23.8%
Q1 FY2020Mar 31, 202036M+66.0%
Q4 FY2019Dec 31, 201936M+102.4%
Q3 FY2019Sep 30, 201934M+88.9%
Q2 FY2019Jun 30, 201932M+79.9%
Q1 FY2019Mar 31, 201922M+22.4%
Q4 FY2018Dec 31, 201818M+0.1%
Q3 FY2018Sep 30, 201818M0.0%
Q2 FY2018Jun 30, 201818M0.0%
Q1 FY2018Mar 31, 201818M+0.0%
Q4 FY2017Dec 31, 201718M-0.0%
Q3 FY2017Sep 30, 201718M–
Q2 FY2017Jun 30, 201718M–
Q1 FY2017Mar 31, 201718M–
Q4 FY2016Dec 31, 201618M–

More CannaPharmaRx figures

See a number that looks wrong?